(Q45797759)
Statements
1 reference
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). (English)
1 reference
H R Kim
1 reference
K H Jung
1 reference
S-A Im
1 reference
Y-H Im
1 reference
S Y Kang
1 reference
K H Park
1 reference
S Lee
1 reference
S-B Kim
1 reference
K-H Lee
1 reference
J S Ahn
1 reference
S I Kim
1 reference
J H Sohn
1 reference
4 February 2013
1 reference
1 reference
24
1 reference
6
1 reference
1485-1490
1 reference
Identifiers
1 reference